teratogenic effect
TRANSCRIPT
-
8/6/2019 Teratogenic Effect
1/12
Teratogenic Effects of Vigabatrin
i n T O Mo u s e F e t u s e sYOUSEF M. ABDULRAZZAQ,1 SALIM M.A. BASTAKI,2 AN D R. PADMANABHAN 3*1Departm ent of Pediatrics, Faculty of Medicine and H ealth S ciences, UAE University, Al A in, Un ited Arab E m irates2Departm ent of Pharm acology, Faculty of Medicine and Health S ciences, UAE University, Al Ain, U nited A rab Em irates3Departm ent of Anatomy, Faculty of Medicine and Health S ciences, UAE University, Al Ain , United Arab Em irates
ABSTRACT Vigabatrin (VGB) is a relativelyrecently introduced antiepileptic drug that enhances thebrain levels of gamma aminobutyric acid (GABA). Fewdata on its teratogenic effects appear to have beenreported. Our objective was to determine if VGB wasteratogenic in the TOmouse. Single doses of 300600
mg/ kg of VGB dissolved in saline were administeredintraperitoneally (IP) to groups of TO mice on one ofgestation days (GD) 712. The controls were salinetreated or untreated. No maternal toxic effects wereobserved in the 300 or 450 mg/ kg groups, and the600 mg/ kg dose was totally lethal to the mothers.Fetuses were collected on GD 18. Both 300 and 450mg/ kg doses induced a consistently significant intrauter-ine growth retardation irrespective of the developmen-tal stage at administration. VGB did not augment thespontaneous incidence of neural tubedefects character-istic of this strain, but accelerated destruction of thebrain in spontaneous exencephalic embryos. Mandibu-lar and maxillary hypoplasia, arched palate, cleft palate(two cases), limb defects (one case), and exomphaloswere observed in the malformed fetuses. The highincidence of exomphalos appears to be a unique resultof VGB treatment. Alizarin red-S/alcian blue-stainedskeletons revealed hypoplasia of mid facial bones,stage-dependent increase in the frequency of cervicaland lumbar ribs, rib fusion, and sternal and vertebralmalformations in the drug-treated fetuses. Middle anddistal phalanges of the forepaw and mid phalanges andtarsals of the hindpaw failed to ossify in a significantnumber of experimental fetuses. Homeotic shift interms of presacral vertebral number and a high inci-dence of lumbar and cervical ribs in the treated group
are suggestive of treatment-related alterations in geneexpression. In view of the paucity of human and animaldata on the reproductive toxicologic effects of VGB, theresults of the present study assume particular impor-tance and suggest that VGB should be used in preg-nancy with extreme caution. Teratology 55:165176,1997. r 1997 Wiley-Liss, Inc.
Epilepsy affects millions of people worldwide. It has
been estimat ed tha t a pproximat ely 0.5% of all pregnan -
cies occur in wom en with epileps y (Svigos, 84; Yerb y,
91). Epileptic women demonst ra te a h igher liability to
obstet ric complicat ions tha n n on-epilepticfemales (Mon-
touris et al., 79). Epilepsy in either paren t is reported
t o b e a s s oci a t ed w it h a n i n cr e a s ed r i sk of h a v i n g a
m a l for m e d i n fa n t (S h a p ir o e t a l ., 7 6; R ob er t a n d
Guibaud, 82; J an z, 82; Lindhout et al., 92; Naka ne
and Kaneko, 92). Congenital malforma tions are esti-ma ted t o be more comm on in infant s of epileptic women
treated with antiepileptic drugs (AEDs) than those of
n or m a l con t r o ls or n on -t r e a t e d e p il ep t ic m ot h e r s
(Meadow, 68; Speidel an d Mea dow, 72; Ann egers et a l.,
78; Kalter an d War ka ny, 83; Nak an e et a l., 80; Speidel
an d Meadow, 72; Kan eko et a l., 88). Both ma jor a nd m inor
malf or mations have been attr ibuted to AED t her apy
(Gailey et a l., 88; Koch et a l., 92). Almost all AEDs h ave
been found to induce some form of fetal malformations,
often described to constitute a syndrome named after
the drug in question. The calculated risk of malforma-
tions in fetuses exposed toAED is 710% (Lindhout and
Omtzigt, 94). Specific risk factors include h igh ma ter-
nal dosage of AED, low folate levels, drug polytherapy,and possible seizure occurrence during pregnancy. Epi-
demiological and experimental studies have corrobo-
ra ted t he t era tological effects of AEDs (Miyagawa et al.,
71; Hanson et al., 84; Dalessio, 85; Kelly, 84; Robert
an d Rosa , 83; Lam mer et a l., 87; Meadow, 91; Mar tin ez-
Fr ias, 90; Yerby, 91; Lindh out et al., 92; Na ka ne an d
Kaneko, 92; Finnel, 91; Padma nabh an and Ham eed,
94; Padma na bhan an d Ahmed, 96). One of the ques-
tions that remains yet unanswered is why only a small
per centage of the AED-exposed fetuses is affect ed,
whereas the majority are not malformed. It is possible
that within the population ther e a r e subpopulat i ons
with a genetic pr edisposit ion who, when exposed t o
AEDs at critical stages of development, become mal-for med (Khour y et al ., 92).One way of test ing t hi s
hypoth esis of dru g-sus ceptibility inter actionis to use
experimental animals with a known susceptibility to a
Contr act gran t s ponsor: UAE University.
*Correspondence t o: R. Padman abhan, Departm ent of Anatomy, Fa c-
ulty of Medicine and H ealth Sciences, UAE Universit y, P.O. Box 1766,
Al Ain, United Arab E mirat es.
Received 5 September 1996; accepted 3 March 1997
TERATOLOGY 55:165176 (1997)
r 1997 WILE Y-LISS, IN C.
-
8/6/2019 Teratogenic Effect
2/12
certain malformation(or malformations) and to deter-
mine if th e AED exposure would a ugment the liability.
The TO mouse is one such strain with a low frequency
of spontaneous neural tube defects (NTDs). We have
recently shown that valproic acid (VPA), a widely used
AE D , i n de ed i n t er a ct s w it h t h i s s u s ce p t ib il it y a n d
e n h a n ce s t h e N TD i n cid en ce (P a d m a n a bh a n a n dAhmed, 96). The s usceptibility is possibly related to th e
inability of the individual t o produce a dequat ely drug-
metabolizing enzymes that are genetically determined
(Strickler et al., 85). Buehler et al. (90) have ident ified
low levels of epoxide h ydrolase a ctivity in children with
fetal h ydantoin syndrome.
Vigabatrin (VGB)gamma-vinyl-GABAis a newly
introduced AED. It is an enzyme-activated, irreversible
inhibitor of GABA-transaminase which enhances brain
GABAlevels in experimenta l animals an d hum ans . The
increase in GABA levels following VGB treatment has
been shown to inhibit the luteinizing hor mone ( LH)
surge and prevent ovulation (Landa an d Donoso, 87)and to decr ease sexual behavior in th e r a t (Qur eshi et
al., 88). VGB a lso crosses th e h uma n placenta l barr ier
in isolat ed prepa ra tions (Challier et a l., 92). One case
each of diaphra gmatic hern ia (Kramer, 92) and hypo-
spadias (Lindhout a nd Omtzigt, 94) has been reported
following th e us e of VGB during pr egna ncy. Mater na lly
toxic doses of VGB h ave been reported t o induce cleft
palate in the rabbit (Merrel Dow file, cited by Grant and
Hee l, 91; Lindh out a nd O mt zigt, 94). To the bes t of our
knowledge, the teratogenic potential of VGB has not
been studied in sufficient detail. Our objectives in this
study were to find out if VGB is teratogenic in the TO
mouse an d to determ ine if VGB would intera ct with the
NTD liability as VPAdid.
MATERIALS AND METHODS
The TO mice used in t his stu dy were virgin females,
about 6 weeks of age an d a pproximat ely 30 g in weight.
T h ey w er e m a i n t a in e d on a com m e r ci a l l a bor a t or y
chow, tap water was provided ad libitum, an d th ey were
housed in light (12:12 hr light:da rk cycle)- an d temp era -
t u r e (2 2 6 1C)-controlled rooms. They were mat ed
with mal es of the same st ock in the eveni ng, and the
presence of a vaginal plug observed on the following
mor ni ng was taken t o indicate gestat ion day ( GD) 0.
Groups of mice were treated intraperitoneally (IP) with
a single dose of 300, 450, or 600 mg/kg of VGB (Marion
Merrell Dow, Paris, France) dissolved in physiological
saline on one of GD 712. This dose regimen was based
on our previous studies on VPA teratogenicity in this
str ain of mice (Padma nabhan and Ahmed, 96). The
contr ols wer e either untr eat ed or administer ed I P a
single dose of saline proportionate to th e h ighest toler-
ated dose of VGB, namely 450 mg/kg. The total fluid
injected corresponded to the body weight and did not
exceed 0.45 ml. The food and water consumption of all
the animals wer e r ecor ded thr oughout the st udy. Al l
animals were killed on GD 18 by cervical dislocation
and the fetuses were collected by hysterotomy. Total
implantation and r esor ption si tes wer e counted. The
fetuses were cleared of their membranes, blotted dry,
weighed and fixed in 95% ethanol, and subsequentl y
examined for malformations. The internal malforma-tions were observed by a modified meth od of Sterz an d
Lehmann (85) and then clear ed in 0.5% solut i on of
potassium hydroxide, processed for alizarin red-S and/or
alcian blue st aining of the skeleton (Inouye, 76), a nd
observed with a stereodissecting microscope. The con-
tr ol data r epor ted her e come f r om the untr eat ed ani -
mals. A total of 112 experimental and 11 control mice
w er e u s e d i n t h i s s t u d y. D a t a on fe t a l w e ig h t w er e
analyzed by Stu dents t- test and malfor mat i on fr e-
quency was analyzed by chi-squar e test with Yat es
corr ection (Elzey, 87). Significan ce was as sum ed wh en
P , 0.05.
RESULTS
M a t e r n a l e f f e c t s
Administration of single doses of 600 mg/kg of VGB
on one of GD 712 was complet ely leth al to th e mother s.
A total of 30 anima ls died within 23 days of trea tmen t.
Lower doses (300 or 450 mg/kg) caused a mild sedation
which lasted 1 or 2 hr. The food and water consumption
and body weight gain did not differ significantly from
those of the control. For example, the controls and the
higher dose (450 mg/kg VGB group treated on GD 8)
group registered on GD 18 increases of 80% and 76%,
respectively, over th eir initia l weight s.
F e t a l e f f e c t s
As noticed in our ear l ier exper iments, sa line t r eat -
ment did not pr oduce significant fetal al ter at i ons i n
compar ison t o the unt reat ed controls an d ther efore the
con t r ol d a t a r e p or t e d h e r e w er e ob t a in e d fr om u n -
tr eated animals. Ther e was a 6% incidence of embr y-
onic resorption in the control animals (Table 1). The
m od e st i n cr e a s e i n r e s or p t ion ob s er v ed i n t h e 3 00
mg/kg VGB trea tmen t group was not sta tistically signifi-
cant. An increase in the dose of VGB only produced a
significant augmentation in r esor ption i n t he GD 11
and 12 treatm ent groups. At least one or two embryos in
each treated litter appeared markedly growth retarded
(Fig. 1). Reduction in fetal body weight was hi ghly
significant (P , 0.05) in all experimenta l groups, irre-
spective of th e dose or sta ge of VGB trea tm ent (Table 1).
Exencephaly, maxillary-mandibular hypoplasia, arched
palate, cleft palate (two cases), and exomphalos oc-
curred in the VGB-treated litters. A low incidence of
sponta neous exen cephaly (3.03.5%) is cha ra cteristic of
the TO str ain used in this study. The dr ug tr eat ment
w a s n ot a s s ocia t e d w it h a n y a u gm e n ta t ion of t h e
background frequency of exencephaly. In VGB-treated
166 Y.M. ABDULRAZZAQ ET AL.
-
8/6/2019 Teratogenic Effect
3/12
-
8/6/2019 Teratogenic Effect
4/12
exencephaly cases, open sku ll defects an d everted mes-
encephalon were associated with exophthalmia, cata-
r act , l ow set micr otia, and maxi llar y an d mandibular
hypoplasia. In some of them, the exposed brain tissue
h a d d e ge n e r a t ed a n d w a s r e p la ce d b y h e m or r h a g ic
capillaries. One of the two fetuses with cleft palate also
had severe mandibular retrognathia, left forelimb ectro-
dactyly of digits 13, and severe growth retardation. In
both fetuses with cleft pa late, the palata l shelves were
h y pop la s t ic (F i g. 2 ). T h e s h e lv es h a d r e a ch e d t h e
dorsum of the tongue but failed to oppose and fuse with
each other. Exompha los occurred in the GD 7, 10, and
F ig . 1 . Mouse fetus es of GD 18. A: Control. BF: Experimental group [(450 mg/kg of VGB, treated on GD
8 (B), 9 (C,D), and 11 (E,F)] shows growth retar dation (B,D), exencephaly a nd exophtha lmos (C),mandibular hypoplasia (C,D,E), and exomphalos (E,F).
168 Y.M. ABDULRAZZAQ ET AL.
-
8/6/2019 Teratogenic Effect
5/12
1 2 g r ou p s t r e a t e d w it h 4 50 m g /k g o f t h e d r u g; t h e
incidence was only significant in the GD 10 group. It
was char a ct er ized by t he pr esence of 210 loops of
intestine in the proximal segment of the umbilical cord
(Fig. 1). In one embr yo, similar loops were foun d t o have
her niated at the par aumbilical r egion of the vent r al
abdominal wall. Such anomalies were not observed in
an y of th e cont rol mice.
F ig . 2. A,B: Razor blade sections of mouse fetu ses of GD 18. A: Contr ol skeleton. Note the cleft palat e due
to p a la ta l sh e lf h y p op la sia (B) in th e tre a te d c a se (45 0 m g /k g o f VG B , tre a te d on G D 9 ). C: control
sk e le ton . O b serv e in th e a liza rin re d -S -sta in e d sk e le ton s of th e fore lim b s o f V GB -tre a te d fetu se s,
phalangeal hypoplasia (DF) and growth retardation.
VIGABATRIN TERATOGENICITY 169
-
8/6/2019 Teratogenic Effect
6/12
TA B LE 2 . A x i a l s k e l e t a l m a l f o r m a t i o n s i n d u c e d b y V GB i n m o u s e f e t u s e s 1
Skeletalelements
Treated
Unt reat edcon t r ol 300 m g/kg VGB 450
7 8 9 10 11 12 7 8 9
No. fet u ses 120 70 91 81 82 80 94 82 70 48
Hypoplaciafacialbon es 4 (3.3) 6 (8.6) 5 (5.5) 6 (7.4) 3 (3.2) 46 (56.1)* 33 (47.1)* 3 (6.3
Rib fu sion 1 (1.4) 3 (3.7) 18 (25.7)* 7/13/6 vert e-
bralcom p le m e n t 9 1 (7 6) 6 4 (9 3)* 7 7 (8 4. 6) 7 3 (9 0. 1)* 7 8 (9 5. 1)* 7 6 (9 5)* 8 9 (9 4. 7)* 7 4 (9 0. 2)* 6 7 (9 5. 7)* 4 7 (9 7.
Coccygealvert ebrae(5 6) 5 4 (4 5) 1 0 (1 4.3 )* 1 4 (1 5.4 )* 3 8 (46 .9) 2 2 (2 6.8 )* 3 0 (3 7.5 ) 35 (3 7.2 ) 3 9 (4 7.6 ) 38 (5 4.3) 3 0 (62 .
Coccygealvert ebrae(7 11 ) 6 1 (5 0.8 ) 5 8 (8 2.9 )* 7 1 (7 8)* 4 3 (5 3. 1) 5 1 (6 2.2 ) 4 3 (5 3.8 ) 50 (5 3.2 ) 3 8 (4 6.3 ) 2 1 (3 0)* 1 5 (3 1.
Lumbar ribs(r igh t ) 1 (0.8) 1 (1.4) 2 (2.2) 1 (1.2) 1 (1.2) 1 (1.3) 2 (2.1) 3 (3.7) 16 (22.9)* 3 (6.3
Lumbar ribs
(left ) 1 (0.8) 1 (1.4) 2 (2.2) 1 (1.2) 1 (1.2) 1 (1.3) 1 (1.1) 3 (3.7) 10 (14.3)* Cervical ribs(r igh t) 8 (6.7) 10 (14.3) 22 (24.2)* 11 (13.6) 3 (3.7) 2 (2.6) 2 (2.1) 44 (53.7)* 8 (11.4) 3 (6.3
Cervical ribs(left ) 8 (6.7) 10 (14.2) 14 (15.4) 8 (9.9) 3 (3.7) 2 (2.6) 2 (2.1) 30 (36.6)* 9 (12.9) 3 (6.3
S t e r n a ld efe ct s 3 (2 .5 ) 5 (7 .1 ) 2 0 (2 2)* 2 6 (4 .9 )* 1 0 (1 2.2 )* 3 (3 .8 ) 1 4 (1 4.9 )* 3 8 (4 6.3 )* 2 3 (3 2. 9)* 2 2 (4 5.
Forepawbones(,4 11 ) 2 1 (1 7.5 ) 8 (11 .4 ) 4 (4 .4 )* 1 6 (1 9. 8) 2 2 (2 6.8 ) 1 5 (1 8.8 ) 15 (1 6.0 ) 1 9 (2 3.2 ) 3 3 (4 7. 1)* 1 4 (2 9.
Forepawbones(54 1 2) 8 6 (8 1. 6) 6 2 (8 8. 6)* 8 7 (9 5. 6)* 6 5 (8 0. 2) 6 0 (7 3. 2) 6 5 (8 1. 3) 7 9 (8 4. 0) 6 3 (7 6. 8) 3 4 (4 8. 6)* 3 4 (7 0.
Hi ndpawbones (,1,5 , 1 2) 4 5 (3 7.5 ) 7 (1 0)* 3 8 (4 1.8 ) 4 7 (5 8)* 2 4 (2 9.3 ) 2 5 (3 1.3 ) 20 (2 1.3 )* 4 6 (5 6.1 )* 4 8 (6 8. 6)* 2 5 (5 2.
Hi ndpawbones (51,5, 12 or
m or e) 7 5 (6 2.5 ) 6 3 (90 )* 5 3 (5 8.2 ) 34 (4 2) 5 8 (70 .7 )* 5 5 (6 8.8 ) 74 (78 .7 )* 3 6 (4 3.9 ) 22 (3 1.4)* 2 3 (47 .Absence of
t a r sa ls 9 (12.9)* 19 (27.1)* 10 (20.MOD 2 (2.9) 33 (40.2)* 14 (8.5)* 5 (10.
1Num e r a ls in pa r e nthe se s a r e pe r c e nta ge s. F or e pa w bone s 5 4 m e ta c a r pa ls, 11 pha la nge s. Hindpa w bone s 5 1 ta r sa l, 5 m emiscellan eous ossificat ion defects (vertebr al a rch fusion, accessory vertebr al a rches, an d occipita lization of atlas).*P , 0.05, contr ol vs. experiment al.
-
8/6/2019 Teratogenic Effect
7/12
S k e l e t a l m a l f o r m a t i o n s
S k u l l . GD 7 a nd 8 were pa rticularly susceptible for
450 mg/kg of VGB-indu ced facial bone hypopla sia (Table
2); the nasal bone, premaxilla, maxilla, and mandible
w er e h y pop la s t i c i n t h e s e e m br y os . I n t h e g r ow t h -
r e t a r d ed fe t u s es of b ot h d os e g r ou p s , t h e p a r ie t a l,
i nter par ietal , and supr aoccipit al bones wer e poor lyos s ifi ed a n d t h e fon t a n e ll es w er e r a t h e r w id e . T h e
petrous pa rt of the t emporal bone a nd t he ossicles of the
inner ear were either hypoplastic or occasionally ab-
sent.
V ertebrae. The control embryos had 7 cervical, 13
thoracic, and 5 or 6 sacral vertebral arches and bodies
each; about 50% also had about 49 coccygeal vertebral
bodi es. About 24% had 25 pr esacr al (7 cer vical , 13
thoracic, an d 5 lumbar ) ver tebr ae and the r est had 26
presacral (7 cervical, 13 thoracic, and 6 lumbar) verte-
brae. All ha d at least 23 coccygeal arches ossified. In
t he GD 8 and 9 VGB- tr eated ( 450 mg/kg) embr yos,
t h e r e w a s a s ig n ifi ca n t i n ci de n ce of v er t e br a l a r ch
fusion (Table 2, F ig. 3); the fusion involved t he t hora cic
and lumbar regions. Occipitalization of the atlas verte-
bra occurred in a bout 7% of embryos of the 450 mg/kg
V G B g r o u p s t r e a t e d o n e i t h e r G D 7 o r 8 (P , 0.05).
Accessory vert ebra l arches wer e comm only found in t he
u p p er ce r vi ca l r e gi on , a l m os t a l wa y s u n i la t e r a l i n
p os it i on a n d oft e n fu s e d w it h t h e a d ja ce n t a r ch e s .
Hemivertebrae were occasionally observed in the lower
thoracic or upper lumbar regions. There was a signifi-
cant s hift from the 25 to 26 presacral vertebra l comple-
ment in al l but the 300 mg/ kg GD 8 tr eat ment gr oup.
Reduction in the number of ossified coccygeal vertebral
b od ie s w a s a ch a r a c t er i st i c f ea t u r e of i n t r a u t er i n e
gr owth r etar dati on (I UGR). I n t he 450 mg/kg VGB
gr oup t r eat ed on one of GD 812, ther e was a 4- f old
i ncr ease i n t he number of f et uses that had only 14
coccygeal vert ebra e ossified.
R i b s . T h ir t e en p a ir s of t h or a ci c r i b s (T R), a 1 %
incidence of lumba r r ibs an d a 7% frequ ency of cervical
ribs, were observed in the controls. The cervical ribs
att ached dorsally to the 7th cervical tr an sverse process;
a bar of car t i lage connected them ventr al ly t o t he 1st
TR. The l umbar r ibs, associated with t he fir st lumbar
ver t ebr a, wer e about 12 o r a l i t t l e m o r e t h a n 12 t h e
length of th e las t TR (Wilson, 73). Those r ibs less t ha n12 the 13th TR were not count ed as supernu mera ry ribs
and so wer e excluded. Dr ug-induced incr ease in the
i n ci de n ce of l u m ba r r i bs w a s h i gh l y s ig n ifi ca n t(P , 0.001) in the GD 8 450 mg/ kg VGB gr oup; in a
large number of these cases, there were 8 sternal ribs,
i n s t e a d o f t h e u s u a l 7 . I n c r e a s e i n t h e i n c i d e n c e o f
cervical ribs was most marked in the GD 7 450 mg/kg
VGB group (P , 0.001). Fu sion involved a ra nge of 24
adjacent ribs an d was often bilat era l in occurr ence. TR3
t o TR10 wer e commonly involved i n fusi on. Fusion
affected the shaft and neck of the ribs (Fig. 3). When
mor e pr oximal segments of the r ibs wer e f used, the
fusion extended t o include t he corresponding vertebra l
ar ches as well . Accessor y ossicles wer e somet imes
p r e se n t b et w ee n t h e v er t e br a e w h en r i b f u s ion oc-
curred.
S t e r n u m . The st ernu m of the contr ol embryos con-
sisted of 7 ster nebr ae; in about 3%, the 5t h ster nebr a
was relatively sma ller than t he rest. Absence or hypopla-
s ia of t h e 5 t h s t er n eb r a , fu s ion of 2 or m or e m idster nebr ae, an d displacement and malposi t ioning of
s t er n e br a e w er e com m on l y ob se r ve d in t h e d r u g-
tr eated embr yos and pr ef er entially in the 450 mg/ kg
group (P , 0.001). Agenesis a ffected invar iably th e 5th
stern ebra. In those fetuses with a lumba r rib, there was
a t e n d en cy for 8 s t e r n a l r i bs r a t h e r t h a n t h e u s u a l 7
(Fig. 4).
S k e l e t o n o f t h e l i m b s . Except for the bones of the
paws, th e rest of the limb sk eleton was n ot affected by
drug treatment. The control fetuses had 4 metacarpals
and 11 (18%) or 12 (82%) phalanges in the forepaw.
They a lso possessed 1 (or occasionally 2) ta rsal(s), 5
metatar sals, and at least 12 phalanges in t he hi ndpaw.
VGB tr eatment affected par ticular ly t he phal angealossification. Most remarkable in the 450 mg/kg group
was the fact th at t he pha langes of the middle and distal
p h a l a n g e s o f t h e f o r e p a w a n d m i d p h a l a n g e s o f t h e
hindpaw remained unossified (Figs. 2, 3). Between 13
and 27% of fetuses of this group did not have a single
ta rsa l bone ossified (Table 2).
D ISC U SSIO N
A thorough literature search showed few published
report s on fetotoxic effects of ma ter na l exposure t o VGB
in an imals and huma ns (Kr amer , 92; Li ndhout and
Omtzigt, 94; Marion Merrel Dow file, cited by Gra nt
and Heel, 91). Kra mer (92) observed a n infan t withdiaphr agmatic her nia following VGB usage dur i ng
pregnan cy. Lindhout and Omtzigt (94) reported 3 s ib-
l in g s, t h e fi r s t of w h i ch h a d h y pos p a d ia s w h en t h e
mother was treat ed with ph enytoin an d carbam azepine.
The second pr egnancy ended in miscar r iage. Dur i ng
her thir d pr egnancy she was on car bamazepi ne and a
male child was born with, in addition to hypospadias,
other featur es l ike br oad nasal br idge, high ar ched
palate, upwar d slant ing of the palpebral fissure, promi-
nent ear lobes, diast asis rectus abdominis, deep palmar
creases, bilater al clinodactyly of the 4th toes, and wide
internipple distance. That carbamazepine is known to
induce hypospadias is a fact (Lindhout et al ., 84;
Editorial, 91) that argues against VGB being the sole
causat ive factor in the r epor ted case. H owever, t hi s
report does not r ule out a possible role for VGB in t he
causation of the abnor malit ies seen. VGB was f ound
not to be ter atogenic in r ats at doses over a r ange of
150500 mg/kg/day. It produced a low incidence of cleft
p a la t e i n t h e r a b b it a t m a t e r n a l ly t ox ic d o sa g es of
150200 mg/kg/day; a d ose of 300 mg/kg/day wa s leth al
to the pr egnant rabbits (cited by Grant an d Heel, 91;
Lindh out a nd Om tzigt, 94).
VIGABATRIN TERATOGENICITY 171
-
8/6/2019 Teratogenic Effect
8/12
F
igure
3.
172 Y.M. ABDULRAZZAQ ET AL.
-
8/6/2019 Teratogenic Effect
9/12
The r esults of this study have shown that a si ngl e
dose of 600 mg/kg of VGB is leth al t o pregna nt TO mice.
Lower doses cause a modest increase in resorption, a
low frequency of craniofacial malformations, various
skeletal defects, and consistent growth retardation of
t h e fe t u s es . I n t h e a b s en ce of o b se r va b le m a t e r n a l
toxicity du e to VGB exposure, th e concordan ce of IUGR
in terms of a significant reduction in fetal weight and
skeletal gr owth inhibit ion should be inter pr et ed as a
dir ect action of th e dr ug on embr yonic gr owt h pr o-
F ig . 4 . Sterna of fetuses of GD 18, stained with alizarin red-S (A,DF ) and/or alizarin plus alcian blue
(B ,C). A: Control. The chest wall together with the sternum and costal elements are dissected out and
shown here. BF: Experimental group treat ed with 450 mg/kg of VGB on GD 8. Observe the 8 st ernal r ibs
(B), scrambling and fusion of stern ebrae (C,E,F), hypoplasia of 5th stern ebra (E,F), and th e unu sual sh ape
of the xyph oid process (C).
F i g . 3 . S k e le ton s of G D 1 8 fetu se s. A: Control. BH: F e tu se s of
experimental group treated with 450 mg/kg of VGB on GD 8 (BG) or
GD 11 (H). Observe occipitalizat ion of atlas vertebr a (open arr ow in B),
cervical ribs anteriorly attached to first rib (C; arrow) or free accessory
vertebral arch (D; arrow), typical lumbar ribs (LR in E), rib fusion
(arrow in E,F), hemivertebrae (open arrow in F), rudimenta ry lumbar
rib s (B ,F ), g row th re ta rd a tio n a n d a b se n ce o f c ra n ia l v a u lt in a n
e xe n ce p h a lic e m b ry o (G ), a n d a b se n ce of m e ta ta rsa ls, ta rsa ls, a n d
phalanges (H; stained with alizarin a nd alcian blue).
VIGABATRIN TERATOGENICITY 173
-
8/6/2019 Teratogenic Effect
10/12
cesses. One of our objectives of th is investiga tion was to
d e t er m i n e i f VG B w ou l d a u g m en t t h e s p on t a n e ou s
incidence ofexencepha ly char acteristic oft he TO mouse.
The r esults indicate that VGB did not i nfluence the
frequency of N TD and tha t VGB-liability gene(s)
interaction did not occur. However, it is important to
note here tha t t he open bra in of exencephalic fetuses ofthe drug-treated embryos had reached advanced stages
of hemorrhagic degeneration. It is not clear from this
study if the drug a ccelerated t he dest ruction of the open
neural tube. Our observation of thousands of embryos
of our colony of the TO str ain over a period of 5 years
indicates no spontaneous incidence of cleft palate, limb
malformat ions, an d exomphalos (Padma nabha n, un pub-
l ished da t a) . I n our study, 2 of the 93 f et uses tr eated
maternally (with 450 mg/kg of VGB) had cleft palate
but a large number of treated fetuses across the board
h a d a r ch e d p a la t e , s u g ge s t in g t h a t t h e d e ve lop in g
mouse palat e is par t icular l y vulner able t o t h e t er ato-
genic effect of VGB. The mid facial h ypoplasia , char ac-
terized by poor development of the nasal bone, premax-illa, ma xilla, and m an dible, is reminiscent of th e clinical
description of facial an omalies reported to r esult from
other anticonvulsant drugs in humans (Tein and Mac-
Gregor, 85) and in experimental a nimals (Padm ana b-
han an d Ha meed, 94; Pa dman abha n a nd Ahmed, 96).
There was a significant incidence of exomphalos in
the trea ted groups. This observation is of major impor-
t a n c e i n i n t er p r e t in g t h e fe t a l e ffe ct s of m a t e r n a l
exposur e to VGB, i n view of t he f act that abdominal
wall defects do not occur spont an eously i n the TO
strain. Abdominal wall defects are suggested to be of
vascular etiology (Van Allen, 81) an d d ue to disr upt ion
of a midline developmental field (Khoury et al., 89).
However, a careful exam ination of our mouse em bryoswith exomphal os r evealed no malfor mat i ons of t he
vitelline or other mesenter ic vessels. E xompha los of
VGB-treated embryos should therefore be considered a
distinctly different ma lforma tion, ar ising possibly from
a mistiming in the reduction of physiological umbilical
hern ia as opposed to the vas cular disruption sequence.
Skeletal malforma tions such a s rib fusion h ave been
report ed t o occur in VPA ter at ogenesis (Kao et a l., 81;
Ong et a l., 83; Pa dman abha n a nd H ameed, 94; Padma-
nabhan and Ahmed, 96). Appr oximately 25% of the
VGB gr oup of embr yos tr eated on GD 8 showed r ib
fusion in th is study. It is worth noting here th at Brown
and Colhoun (84) and our gr oup (Padma nabhan and
Ham eed, 94) have reported tha t VPA caus es defective
segment ati on of t he somites leading to ver t ebr al and
costal fusi on. Taken together, th ese dat a poi nt to th e
possibility that antiepileptic agents may share a com-
mon mechanism in embryonic dysmorphogenesis. The
implications of supernumerary ribs (SNR) in teratology
a r e d e b a t e d . M a t e r n a l s t r e s s d u r i n g p r e g n a n c y a n d
t r eatments with chemical s or dr ugs incl uding AED
(e .g ., VP A) h a v e b ee n s h ow n t o r e s u lt i n S N R i n
experimen ta l an imals (Wilson, 64, 73; Beyer an d Ch er-
noff, 86; Ong et al., 83; Pet rer e et al., 86; Pa dma na b-
han et al ., 94; Padman abhan and Ahmed, 96). VGB
administer ed on GD 7 accentuated the inci dence of
cer vical r ibs and injection on GD 8 augment ed t he
frequency of lumbar ribs and 8 sternal ribs. VGB also
significantly promoted the occurrence of 26 presacral
vertebral complement and sternal anomalies. Changesi n t h e n u m b e r of v e r t eb r a e , s t e r n eb r a e , a n d r i bs i n
response to teratogenic treatments commonly referred
t o a s a homeotic shift are considered a morphological
sign that developmental interference has occurred (Rus-
sel, 79). Ribs are a t hora cic cha ra cteristic. Persist ence
of th e costal elements in the lower cer vical r egion
(cer vical r ib) or upper lumbar r egion (lumbar r ib)
possibly results from misexpression of H ox 3.3 genes.
Such homeotic tr an sfor mations h ave been shown t o
occur in transgenic mice and after maternal treatment
with r etinoic acid, a key molecule in patt ern formation
(Kessel, 92; Kessel an d Gruss, 91; J egalian and De
Robertis, 92). Wherea s VPA indu ced a modera te red uc-
tion in t he frequency of 26 pr esacral vertebra l comple-ment, VGB enhanced the incidence significantly. The
mecha nism of th e differentia l response is not clear from
this study. That the phalangeal hypoplasia and failure
of ossification of the tarsal bones and of caudal verte-
brae were a s consistent as IUGR ma y be a reflection of
the overall growth-retarding effect of VGB treatment.
The phar ma cokinetics of most of t he anti epil epti c
agents are similar (Thomson and Brodie, 92). They are
well absorbed, bind to serum albumin (except VGB and
ethosuximide), and are mainly eliminated by metabo-
lism in th e liver. Their a bility to induce hepa tic monooxy-
genase or to act a s enzyme inhibitor s r esult s in dr ug-
drug interactions. Close relationships between serum
concentration and observed therapeutic and toxicologi-cal effects are well known for many of them, but such a
r elationship is n on- existent with VGB. VGB ha s an
elimination half-l ife of 57 hr and a r elat ivel y long
dura tion of action (2445 hr ) because it irr eversibly
b in d s t o t h e t a r ge t e n zy me . I t a p pe a r s t o h a ve a
negligible influence on hepatic metabolism and is ex-
creted in th e urine largely un changed (Gran t an d Heel,
91). I ts effects on the developing embr yos wil l be
deter mined by several factors such as th e dose, develop-
m e n t a l s t a g e a t a d m in i st r a t i on , a b il it y t o cr os s t h e
placenta l barr ier, ma terna l-fetal ph arm acokinetics, an d
genotype of the mother and the conceptus. The results
of th is stu dy in par ticular, and t hose of previous investi-
gators on AED teratogenesis in general, clearly showthat VGB is not as str ongly ter atogenic as VPA and
other AEDs and that VGB has a significantly deleteri-
ous effect on em bryonic growth.
ACKNOWLEDGMENTS
T h e a u t h or s a r e g r a t efu l t o P o n er y S . S a m a d , I ja z
Ahmed, and Mohamed Shafiullah for excellent techni-
cal support and Ashok Prasad for photographic assis-
tance. Ms. Janet C. Powell kindly read the manuscript
174 Y.M. ABDULRAZZAQ ET AL.
-
8/6/2019 Teratogenic Effect
11/12
a n d m a d e m a n y u s e fu l s u gg es t ion s . T h is w or k w a s
g en e r ou s ly s u p p or t e d b y U A E U n iv er s it y a n d b y a
t r a v el g r a n t fr om H oe ch s t M a r ion R ou s s el of A bu
Dhabi.
LITERATURE CITED
Annegers, J .F., W.A. Hau ser, L.R. Elveback, V.E. Anderson, a nd L.T.
Kuriand (1978) Congenital m alforma tions and seizure disorders in
the offspring of parents with epilepsy. Int. J. Epidemiol., 7:241247.
Beyer, P.E., and N. Chern off (1986) The induction of supern umera ry
rib s in ro d en ts: R ole o f m a te rn a l stre ss. Te ra to ge n . C a rcin og en .
Mutagen., 6:416429.
Brown, N.A., and C.W. Colhoun (1984) Valproic acid teratogenesis. I.
In vivo/in vitro compar isons and effects on somite morphogenesis.
Teratology, 29:2021A.
Buehler, B.A., D. Delimont, M. Van Waer, and R.H. Finnel (1990)
Prena tal pr ediction of risk of fetal hydantoin syndrome. N. En gl. J.
Med., 322:15671572.
Challier, J.C., E. Rey, T. Bintein, and G. Olive (1992) Passage of S(1)
a n d R (2) gamma-vinyl-GABA across the human isolated perfused
placenta . Br. J. Clin. Phar macol., 34:139143.
Dalessio, D.J. (1985) Medical intelligence: Current concepts, seizure
disorders and pregnancy. N. Engl. J. Med., 312:559563.
Editorial (1991)Terat ogenesis with carbamazepine. Lancet, 337:1316
1317.
Elzey, F.F. (1987) Introductory Statistics: A Microcomputer Approach.
Adopted for IBM-PC by R.D. Cloward. Brooks/Cole Publishing Co.,
Monterey, CA.
Finnel, R.H. (1991) Genetic differences in susceptibility to anticonvul-
sant drug-induced developmental defects. Pharmacol. Toxicol., 69 :
223227.
Gailey, E ., M.L. Gran strom, V. H ilesmaa, a nd A. Ba rdy (1988) Minor
anomalies in offspring of epileptic mothers. J. Pediatr., 112:520529.
Grant , S.M., and R.C. Heel (1991) Vigabatrin: A review of its ph arm a-
codynamic and ph arm acokinetic properties, an d th erapeutic poten-
tial in epilepsy and disorders of motor control. Drug, 41:889926.
Hans on, J.W., H.H. Ardinger, J. Di Liberti, et al. (1984) Effects of
valproic acid on the fetus. Pediatr. Res., 18:306A.
Inouye, M. (1976) Differential st aining of cartilage an d bone in fetal
m o u se sk e le ton b y a lc ia n b lu e a n d a liza rin re d -S . C o n g en ita l
Anomalies, 16:171173.
Janz, D. (1982) On major malformations and minor anomalies in the
offspring of parents with epilepsy. In: E pilepsy, Pr egnancy and the
C h ild . D . Ja n z , L . B o ssi, M. D a m , H . H e lg e , A . R ic h e n s, a n d S .
Schmidt , eds. Raven Pr ess, New York, pp. 221222.
Jegalian, B.G., an d E .M. De Robertis (1992) Homeotic tr ansformation
i n t h e m ou s e i n du ce d b y o ve r ex pr e s si on of a h u m a n H ox 3.3
tra nsgene. Cell, 71:901910.
Kalter, H., and J . Warka ny (1983) Congenital m alforma tions. N. Engl.
J . Med., 308:491497.
Kaneko, S., K. Ota ni, Y. Fu kushima , et al. (1988) Teratogenicity of
ant iepileptic drugs: Analysis of possible risk factors. Epilepsia,
29:459467.
Kao, J., N.A. Brown, B. Schmids, E.H. Goulding, and S. Fa bro (1981)
Teratogenicity of valproic acid in vivo an d in vitro investigations.
Teratogen. Carcinogen. Mutagen., 1:367382.Kelly, T.E. (1984) Tera togenicity of ant iconvulsa nt dru gs. I. Review of
the litera tur e. Am. J . Med. Genet., 19:413434.
Kessel, M. (1992) Respecification of vertebral identities by ret inoic
acid. Development, 115:44874501.
Kessel, M., and P. Gruss (1991) Homeotic trans forma tions of murine
v erte b ra e a n d c on c om ita n t a lte ra tion s o f H ox codes induced by
ret inoic acid. Cell, 67 :89104.
K h ou ry, M. J. , J . F. C ord e ro, J. Mu lin a re , a n d J. M. O p itz (19 8 9)
Selected midline associations:Apopulation study. Pediatrics, 84:266
272.
Khoury, M.J., L.M. James, W.D. Flanders, and J.D. Erickson (1992)
Interpretation of recurring weak associations obtained from epide-
miological stu dies ofsu spected hum an t erat ogens. Teratology, 46:69
77.
K oc h , S . , G . L o e sch e , E . Ja g e r R om a n , e t a l . (1 9 92 ) Ma jor b irth
malforma tions a nd ant iepileptic drugs. Neurology, 42(Suppl 5):83
88.
Kramer, G. (1992) Vigabatrin: Wisksmkeit und Vertrag lichkeit bei
epilepsein in Erwachsenenalter. Akt. Neurol., 19:S28S40.
L a m m e r, E . J. , L .E . S e ve r, a n d G .P. O a k ley, Jr (19 8 7) Te ra to ge n
upda te: Valpr oic acid. Teratology, 35:465473.
Landa , A.I., and A.O. Donoso (1987) Blockade of pro-oestr us LH s ur ge
and ovulation by GABA increase in the rat locus coeruleus. Acta
End ocrinol. Copenh., 115:490496.
Lindhout , D., and J .G.C. Omt zigt (1994) Tera togenic effects of ant iepi-
leptic drugs: Implications for the management of epilepsy in women
of childbearing age. Epilepsia, 35(Suppl 4):S19S28.
Lindhout, D., H. Meinardi, J .W.A. Meijer, et al. (1992) Antiepileptic
d ru g s a n d te ra to ge n e sis in tw o c on se cu tiv e c oh o rts: C h a n g e s in
prescription policy, paralleled by changes in pattern of malforma-
tions. Neur ology, 42(Suppl):94110.
Lindhout, D., J.E. Rene, and H. Meinardi (1984) Teratogenicity of
ant iepileptic drug combinat ions with special empha sis on oxidation
(of carbamazepine). Epilepsia, 25:7783.
Martinez-Frias, M.L. (1990) Clinical ma nifestation of prenat al expo-
sure to valproic acid using case reports and epidemiologic informa -
tion. Am. J. Med. Genet., 37:277282.Meadow, R. (1991) Anticonvulsants in pregnancy. Arch. Dis. Ch ild.,
66:6265.
Meadow, S.R. (1968) Anticonvulsant drugs and congenital abnormali-
ties. Lancet, 2:1296.
Miyagawa, A., T. H ara , T. Okura , et al. (1971) Toxicity testing of
sodium dipropylacetateAcute toxicity, subacute toxicity and tera-
togenicity testing. Clin. Rep., 5:4165.
Montouris, G.D., G.M. Fenichel, and W. McLain (1979) The pregnant
epileptic. Arch. N eur ol., 36:601603.
N a k a n e , Y. , a n d S . K a n e k o (19 9 2) C o n g en ita l a n o m a lie s in th e
offspring of epileptic mother s. Congenita l Anomalies, 32:309321.
Nakan e, Y., T. Okum a, R. Takashi, et al. (1980) Multi-institut ional
study on the tera togenicity an d fetal t oxicity of antiepileptic drugs:
A report of collaborative study group in Japan. Epilepsia, 21 :663
680.
O n g , L .I. , J. L . S c h a rd e in , J . A. P e tr e re , R . S a k o w sk i, H . J o rd a n , R .
Humphrey, J.E. Fitzgerald, and F.A. Iglesia (1983) Teratogenesis ofcalcium valproat e in ra ts. F und am. Appl. Toxicol., 3:121126.
Padmanabhan, R., and I. Ahmed (1996) Sodium valproate augments
spontaneous neura l tube defects a nd axial skeletal malformations in
TO m ouse fetu ses. Repr od. Toxicol. 10:345363.
Padmanabhan, R., and M.S. Hameed (1994) Exencephaly and axial
sk e le ta l m a lfo rm a tion s in d u ce d b y m a t e rn a l a d m in istra tion of
sodium valproate in the MF1 mouse. J. Craniofac. Genet. Dev. Biol.,
14:192205.
Padma nabha n, R., I.A. Wasfi, and M.B.L. Craigmyle (1994) Effect of
pre-treatment with aspirin on alcohol-induced neural tube defects
in th e TO mouse fetus es. Drug Alcohol Depend., 36:175186.
Petrer e, J .A., J .A. Anderson, R. Sakowski, J.I.E. F itzgerald, a nd F.A.
De La Iglesia (1986) Teratogenesis of calcium valproate in rabbit.
Teratology, 34 :263269.
Q u re sh i, G . A. , I . B a d n a r, B . G . F o rsb e rg, a n d P. S od e rste n (19 8 8)
GABAinhibits sexual behavior in female rats. Neuroscience, 27:169
174.Robert, E., and P. Guibaud (1982) Maternal valproic acid and congeni-
tal n eural t ube defects. Lancet, 2:937.
Robert, E., and F. Rosa (1983) Valproate and birth defects. Lancet,
2:1142.
Russell, L.B. (1979) Sensitivity patterns for the induction of homeotic
shifts in a favoura ble str ain of mice. Terat ology, 20:115126.
S h a p iro, S . , S . C . H a rtz , V. S isk in d , A .A . Mitc h ell, D . S lon e , L .
Rosenberg, P.R. Monson, an d O.P. Heinonen (1976) Anticonvulsan ts
and prenatal epilepsy in the development of birth defects. Lancet,
1:272275.
Speidel, B.D., an d S.R. Meadow (1972) Matern al epilepsy and abnor-
malities of the fetus an d the n ewborn. Lancet, 2:839843.
VIGABATRIN TERATOGENICITY 175
-
8/6/2019 Teratogenic Effect
12/12
S t e r z, H . , a n d H . L eh m a n n ( 19 85 ) A cr i t ica l com p a r i son of t h e
freehand razor blade dissection method according to Wilson with an
in situ sectioning met hod for rat fetuses. Teratogen. Carcinogen.
Mutagen., 5:347354.
Strickler, S.M., M.A. Miller, E. Andermant , L.V. Dansky, M.H. Seni,
and S.P. Spielberg (1985) Genetic predisposition to ph enytoin in-
duced birth defects. Lancet, 5:746749.
Svigos, J.M. (1984) Epilepsy and pregnancy. Aust. N.Z. J. Obstet.
Gynaecol., 24 :182185.
Tein, I., and D.L. MacGregor (1985) Possible valproate teratogenicity.
Arch. Neurol., 42:291293.
Thomson, A.H., and M.J. Brodie (1992) Pharmacokinetic optimization
of anticonvulsant ther apy. Clin. Pha rma cokinet., 23:216230.
Van Allen, M.I. (1981) Fetal vascular disruptions: Mechanisms and
some resulting birth defects. P ediatr. Ann., 10:219233.
Wilson, J.G. (1964) Terat ogenic interaction of chemical agents in the
rat . J. P har macol. Exp. Ther., 144:429436.
Wilson, J.G. (1973) Environment and Birth Defects. Academic Pr ess,
New York .
Yerby, M.S. (1991) Pregna ncy an d epilepsy. Epilepsia, 32(Suppl 6):51
59.
176 Y.M. ABDULRAZZAQ ET AL.